London · Delayed Price · Currency is GBP · Price in GBX Evoke Earnings Call Transcripts
Fiscal Year 2025
-
Revenue grew 2% to £1.8bn and adjusted EBITDA rose 14% to £356m, with strong Q4 momentum and improved margins. Strategic review is ongoing, retail optimization and AI investments are driving efficiency, and deleveraging remains a key focus.
-
Delivered fourth consecutive quarter of revenue growth and a 44% year-over-year increase in adjusted EBITDA, driven by strong international performance and operational improvements. Leverage reduced to 5x, with guidance for 5%-9% revenue growth and at least 20% EBITDA margin in 2025 reiterated.
-
The meeting highlighted a successful business transformation, renewed revenue growth, and a focus on customer acquisition and efficiency. A new Technology Committee was established to enhance governance. Management addressed shareholder questions and expects share price improvement as goals are achieved.
Fiscal Year 2024
-
2024 marked a successful turnaround with 3% revenue growth and 4% higher adjusted EBITDA, driven by transformation, cost efficiencies, and a focus on core markets. The outlook targets 5%-9% revenue growth and at least 20% EBITDA margin in 2025, with continued deleveraging and strategic investments.
-
H1 2024 saw a 2% revenue decline and lower-than-expected EBITDA, but corrective actions and strategic transformation are driving improved Q3 trading and set up for 5%-9% revenue growth in H2. Liquidity remains strong, and cost savings plus new product launches support profitability.
-
H1 2024 revenue was £862m, down 2% year-on-year but up 4% from H2 2023, with EBITDA guidance revised down by £35m-£40m. Strategic changes, cost savings, and new product launches are expected to drive 5%-9% revenue growth and margin recovery in H2 and beyond.